Intact MET Immunoassay
BRD ID: 2,246
Source: DCTD Tier: SOP Number of times downloaded: 721
Description
This document describes quantification of MET levels in lysates of frozen needle tumor biopsies using the Intact MET Immunoassay. It is a product of the National Cancer Institute's (NCI) Division of Cancer Treatment and Diagnosis (DCTD; https://dctd.cancer.gov/). Please check the DCTD website (https://dctd.cancer.gov/drug-discovery-development/assays) for the current SOP version.
Documents for Download
SOP341203_Intact_METIA.pdf [Size: 389 KB]Biospecimens
- Tissue - General
Diagnoses
- Neoplastic - Not specified
- General
Topics
- Platform-specific Methodology
Associated SOP Compendiums
- Platform-specific Methodology